|
|
||||||||
The Journal of Immunology, Vol 152, Issue 11 5532-5539, Copyright © 1994 by American Association of Immunologists
ARTICLES |
RI Fox, HI Kang, D Ando, J Abrams and E Pisa
Department of Rheumatology and Immunology, Scripps Clinic and Research Foundation, La Jolla, CA 92037.
Sjogren's syndrome is a human autoimmune disease characterized by lymphocytic infiltration of salivary and lacrimal glands, hypergammaglobulinemia, and specific autoantibodies. The accessibility of the salivary gland to biopsy provides an opportunity to study cytokine mRNA expression at the site of organ-specific immune damage. Using reverse transcriptase and a quantitative PCR to measure cytokine mRNA, we found Sjogren's syndrome: 1) salivary gland CD4+ T cells produce over 40-fold more IL-2, IFN-gamma, and IL-10 mRNA than peripheral blood CD4+ T cells from the same patient or from normal controls; 2) salivary gland CD4+ T cells produced little IL-4 and IL-5 mRNA immediately after elution from the salivary gland, although these mRNAs could be induced by mitogen stimulation of Sjogren's syndrome salivary gland lymphocytes in vitro; 3) salivary gland epithelial cells produced over 40-fold more IL-1 alpha, IL-6, and TNF-alpha mRNA than epithelial cells from individuals with histologically normal salivary glands. Increased levels of IL-1 alpha, IL-6, IL-10, TNF-alpha, and IFN- gamma cytokines were found by ELISA assay in the saliva of Sjogren's syndrome patients, indicating that the elevated mRNA levels detected in their glandular tissue by PCR correlate with local protein synthesis. Our results demonstrate that CD4+ cells in the salivary glands of Sjogren's syndrome patients exhibit mRNA expression that is distinct from previously described Th1 and Th2 lymphocytes in mice or cytokines reported in other human autoimmune or allergic diseases. Also, we found that salivary gland epithelial cells may participate in the pathogenesis of Sjogren's syndrome biopsy by producing cytokines (IL-1 alpha, IL-6, and TNF-alpha).
This article has been cited by other articles:
![]() |
G. E. Katsifis, S. Rekka, N. M. Moutsopoulos, S. Pillemer, and S. M. Wahl Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjogren's Syndrome Immunopathogenesis Am. J. Pathol., September 1, 2009; 175(3): 1167 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bende, F. van Maldegem, and C. J.M. van Noesel Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas Haematologica, August 1, 2009; 94(8): 1109 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Baker, J. M. Camden, R. S. Redman, J. E. Jones, C. I. Seye, L. Erb, and G. A. Weisman Proinflammatory cytokines tumor necrosis factor-{alpha} and interferon-{gamma} alter tight junction structure and function in the rat parotid gland Par-C10 cell line Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1191 - C1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Alliende, Y-J Kwon, M Brito, C Molina, S Aguilera, P Perez, L Leyton, A F G Quest, U Mandel, E Veerman, et al. Reduced sulfation of muc5b is linked to xerostomia in patients with Sjogren syndrome Ann Rheum Dis, October 1, 2008; 67(10): 1480 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakai, Y. Sugawara, T. Kuroishi, T. Sasano, and S. Sugawara Identification of IL-18 and Th17 Cells in Salivary Glands of Patients with Sjogren's Syndrome, and Amplification of IL-17-Mediated Secretion of Inflammatory Cytokines from Salivary Gland Cells by IL-18 J. Immunol., August 15, 2008; 181(4): 2898 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sekiguchi, T. Iwasaki, M. Kitano, H. Kuno, N. Hashimoto, Y. Kawahito, M. Azuma, T. Hla, and H. Sano Role of Sphingosine 1-Phosphate in the Pathogenesis of Sjogren's Syndrome J. Immunol., February 1, 2008; 180(3): 1921 - 1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Jabs, R. A. Prendergast, A. L. Campbell, B. Lee, E. K. Akpek, H. C. Gerard, A. P. Hudson, and J. A. Whittum-Hudson Autoimmune Th2-Mediated Dacryoadenitis in MRL/MpJ Mice Becomes Th1-Mediated in IL-4 Deficient MRL/MpJ Mice Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5624 - 5629. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wakamatsu, Y. Nakamura, I. Matsumoto, D. Goto, S. Ito, A. Tsutsumi, and T. Sumida DNA microarray analysis of labial salivary glands of patients with Sjogren's syndrome Ann Rheum Dis, June 1, 2007; 66(6): 844 - 845. [Full Text] [PDF] |
||||
![]() |
J. S. Oak, J. A. Deane, M. G. Kharas, J. Luo, T. E. Lane, L. C. Cantley, and D. A. Fruman Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase PNAS, November 7, 2006; 103(45): 16882 - 16887. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Ryu, J. C. Atkinson, G. T. Hoehn, G. G. Illei, and T. C. Hart Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis Rheumatology, September 1, 2006; 45(9): 1077 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Pertovaara, J Antonen, and M Hurme Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome Ann Rheum Dis, May 1, 2006; 65(5): 666 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Aragona, R Di Pietro, R Spinella, and M Mobrici Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome Br J Ophthalmol, February 1, 2006; 90(2): 166 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Molina, C Alliende, S Aguilera, Y-J Kwon, L Leyton, B Martinez, C Leyton, P Perez, and M-J Gonzalez Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration Ann Rheum Dis, February 1, 2006; 65(2): 178 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M van Woerkom, A A Kruize, M J G Wenting - van Wijk, E Knol, I C Bihari, J W G Jacobs, J W J Bijlsma, F P J G Lafeber, and J A G van Roon Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren's syndrome compared with non-Sjogren's sicca syndrome Ann Rheum Dis, October 1, 2005; 64(10): 1474 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bredberg, G. Henriksson, A. Larsson, R. Manthorpe, and A. Sallmyr Sjogren's syndrome and the danger model Rheumatology, August 1, 2005; 44(8): 965 - 970. [Full Text] [PDF] |
||||
![]() |
E C Keystone The utility of tumour necrosis factor blockade in orphan diseases Ann Rheum Dis, November 1, 2004; 63(suppl_2): ii79 - ii83. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Jabs, H. C. Gerard, Y. Wei, A. L. Campbell, A. P. Hudson, E. K. Akpek, B. Lee, R. A. Prendergast, and J. A. Whittum-Hudson Inflammatory Mediators in Autoimmune Lacrimal Gland Disease in MRL/Mpj Mice Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2293 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhu, D. Stevenson, J. E. Schechter, A. K. Mircheff, T. Ritter, L. Labree, and M. D. Trousdale Prophylactic Effect of IL-10 Gene Transfer on Induced Autoimmune Dacryoadenitis Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1375 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ruhl, S. Hamberger, R. Betz, T. Sukkar, G. Schmalz, R.A. Seymour, K.-A. Hiller, and J.M. Thomason Salivary Proteins and Cytokines in Drug-induced Gingival Overgrowth Journal of Dental Research, April 1, 2004; 83(4): 322 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Akpek, D. A. Jabs, H. C. Gerard, R. A. Prendergast, A. P. Hudson, B. Lee, and J. A. Whittum-Hudson Chemokines in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 185 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pertovaara, J. Hulkkonen, J. Antonen, P. Holopainen, P. Laippala, A. Pasternack, and M. Hurme Polymorphism of the tumour necrosis factor-{alpha} gene at position -308 and renal manifestations of primary Sjogren's syndrome Rheumatology, January 1, 2004; 43(1): 106 - 107. [Full Text] [PDF] |
||||
![]() |
M R Kok, B J Baum, P P Tak, and S R Pillemer Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjogren's syndrome Ann Rheum Dis, November 1, 2003; 62(11): 1038 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Willeke, H Schotte, B Schluter, M Erren, H Becker, A Dyong, E Mickholz, W Domschke, and M Gaubitz Interleukin 1{beta} and tumour necrosis factor {alpha} secreting cells are increased in the peripheral blood of patients with primary Sjogren's syndrome Ann Rheum Dis, April 1, 2003; 62(4): 359 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jimenez, S. Aiba-Masago, I. Al Hashimi, N. Vela-Roch, G. Fernandes, C.-K. Yeh, N. Talal, and H. Dang Activated caspase 3 and cleaved poly(ADP-ribose)polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjogren's syndrome Rheumatology, March 1, 2002; 41(3): 338 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cha, A.B. Peck, and M.G. Humphreys-Beher PROGRESS IN UNDERSTANDING AUTOIMMUNE EXOCRINOPATHY USING THE NON-OBESE DIABETIC MOUSE: AN UPDATE Critical Reviews in Oral Biology & Medicine, January 1, 2002; 13(1): 5 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Jabs, R. A. Prendergast, E. M. Rorer, A. P. Hudson, and J. A. Whittum-Hudson Cytokines in Autoimmune Lacrimal Gland Disease in MRL/MpJ Mice Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2567 - 2571. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Inoue, K. Tsubota, M. Ono, Y. Kizu, F. Mizuno, K. Takada, K. Yamada, K. Yanagi, Y. Hayashi, and I. Saito Possible Involvement of EBV-Mediated {{alpha}}-Fodrin Cleavage for Organ-Specific Autoantigen in Sjogren's Syndrome J. Immunol., May 1, 2001; 166(9): 5801 - 5809. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Matsumura, K Umemiya, T Goto, T Nakazawa, M Kagami, H Tomioka, E Tanabe, T Sugiyama, and M Sueishi Glandular and extraglandular expression of costimulatory molecules in patients with Sjogren's syndrome Ann Rheum Dis, May 1, 2001; 60(5): 473 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zoukhri and C. L. Kublin Impaired Neurotransmitter Release from Lacrimal and Salivary Gland Nerves of a Murine Model of Sjogren's Syndrome Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 925 - 932. [Abstract] [Full Text] |
||||
![]() |
M. Yamakawa, R. Weinstein, T. Tsuji, J. McBride, D. T. W. Wong, and G. R. Login Age-related Alterations in IL-1{beta}, TNF-{alpha}, and IL-6 Concentrations in Parotid Acinar Cells from BALB/c and Non-obese Diabetic Mice J. Histochem. Cytochem., August 1, 2000; 48(8): 1033 - 1042. [Abstract] [Full Text] |
||||
![]() |
M. D. S. Jean, C. Debbasch, M. Rahmani, F. Brignole, G. Feldmann, J.-M. Warnet, and C. Baudouin Fas- and Interferon {gamma}-Induced Apoptosis in Chang Conjunctival Cells: Further Investigations Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2531 - 2543. [Abstract] [Full Text] |
||||
![]() |
D. A. Jabs, B. Lee, J. A. WhittumHudson, and R. A. Prendergast Th1 Versus Th2 Immune Responses in Autoimmune Lacrimal Gland Disease in MRL/Mp Mice Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 826 - 831. [Abstract] [Full Text] |
||||
![]() |
Y. Hiromatsu, D. Yang, T. Bednarczuk, I. Miyake, K. Nonaka, and Y. Inoue Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1194 - 1199. [Abstract] [Full Text] |
||||
![]() |
M. D. S. Jean, F. Brignole, G. Feldmann, A. Goguel, and C. Baudouin Interferon-{gamma} Induces Apoptosis and Expression of Inflammation-Related Proteins in Chang Conjunctival Cells Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2199 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujihara, H. Fujita, K. Tsubota, K. Saito, K. Tsuzaka, T. Abe, and T. Takeuchi Preferential Localization of CD8+ {alpha}E{beta}7+ T Cells Around Acinar Epithelial Cells with Apoptosis in Patients with Sjogren's Syndrome J. Immunol., August 15, 1999; 163(4): 2226 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Saito, K. Haruta, M. Shimuta, H. Inoue, H. Sakurai, K. Yamada, N. Ishimaru, H. Higashiyama, T. Sumida, H. Ishida, et al. Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10 J. Immunol., March 1, 1999; 162(5): 2488 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tishler, I. Yaron, I. Shirazi, and M. Yaron Salivary and serum hyaluronic acid concentrations in patients with Sjogren's syndrome Ann Rheum Dis, August 1, 1998; 57(8): 506 - 506. [Abstract] [Full Text] |
||||
![]() |
N. Tanda, H. Ohyama, M. Yamakawa, M. Ericsson, T. Tsuji, J. McBride, A. Elovic, D. T. W. Wong, and G. R. Login IL-1beta and IL-6 in mouse parotid acinar cells: characterization of synthesis, storage, and release Am J Physiol Gastrointest Liver Physiol, January 1, 1998; 274(1): G147 - G156. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meehan, A. J. Wu, E. C. Kang, T. Sakai, and I. S. Ambudkar Interferon-gamma induces a decrease in the intracellular calcium pump in a human salivary gland cell line Am J Physiol Cell Physiol, December 1, 1997; 273(6): C2030 - C2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Royer, D. Cazals-Hatem, J. Sibilia, F. Agbalika, J.-M. Cayuela, T. Soussi, F. Maloisel, J.-P. Clauvel, J.-C. Brouet, and X. Mariette Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses Blood, July 15, 1997; 90(2): 766 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.C. Fox and P.M. Speight Current Concepts of Autoimmune Exocrinopathy: Immunologic Mechanisms in the Salivary Pathology of Sjogren's Syndrome Critical Reviews in Oral Biology & Medicine, January 1, 1996; 7(2): 144 - 158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |